A cross-sectional follow up study to estimate seroprevalence of coronavirus disease 2019 in Kobe, Japan일본 고베에서 2019년 코로나바이러스 질환의 혈청 유병률을 추정하기 위한 횡단면 추적 연구Article Published on 2021-12-032022-09-11 Journal: Medicine [Category] SARS, 진단, 치료기술, [키워드] 95% CI 95% confidence interval Abbott acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 added adjusted age and sex antibody calculated census Chain Reaction city clinic conducted coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 cross-sectional cross-sectional study False positive Follow-up identify IgG Immunoglobulin Immunoglobulin G Japan Kobe Patient PCR polymerase chain polymerase chain reaction positive Prevalence respiratory SARS-CoV-2 Sensitivity and specificity serologic testing serology assay serology assays Seroprevalence serum sample serum samples severe acute respiratory syndrome Coronavirus Sex spread of COVID-19 stratified study period true positive true positives validation study [DOI] 10.1097/MD.0000000000028066 PMC 바로가기 [Article Type] Article
Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer A US Nationwide Veterans Affairs Study암 환자의 SARS-CoV-2 감염과 COVID-19 예방 접종의 연관성 미국 전역 재향 군인 연구Multicenter Study Published on 2021-12-022022-09-10 Journal: JAMA Oncology [Category] COVID19(2023년), MERS, SARS, 치료기술, [키워드] 1:1 95% CI Affair age association Cancer cancer type Care Chemotherapy Cohort cohort study Control controls COVID-19 COVID-19 vaccination death defined determine dose effective Effectiveness eligibility criteria eligible Endocrine Endocrine Therapy Ethnicity exposure finding first vaccination Follow-up for inclusion Health Health care Health care system hematologic Immunosuppressed Importance increased risk individuals Infection infection rate measure median multicenter objective outcomes participant Patient patients Patients with cancer Point positive result Primary outcome receipt receiving Relevance Result risk risk ratio risk reduction rurality SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 vaccination SARS-CoV-2 vaccine second dose serologic testing setting severe COVID-19 solid tumor solid tumors subgroup systemic therapy the vaccine therapy Treatment tumors vaccinated individual vaccinated individuals vaccination Vaccine vaccine dose vaccine response veteran white [DOI] 10.1001/jamaoncol.2021.5771 PMC 바로가기 [Article Type] Multicenter Study
Infection prevention strategies are highly protective in COVID-19 units while main risks to healthcare professionals come from coworkers and the communityResearch Published on 2021-11-222022-10-28 Journal: Antimicrobial Resistance and Infection Control [Category] COVID-19, MERS, [키워드] article assigned association being Care Community Comorbidities conducted contributing to COVID-19 COVID-19 outbreaks COVID-19 patient COVID-19 seroprevalence cross-sectional demographics evaluated Factor hcp Healthcare professional Healthcare professional COVID-19 exposure Healthcare worker COVID-19 exposure Infection prevention Latino male occupational occurred offered outbreak Outbreaks Participants Personal protective equipment positive serology Prevent Protective protocol Research respiratory viruses Result retrospective cohort risk SARS-CoV-2 antigens serologic testing seropositive individual severe acute respiratory syndrome coronavirus-2 single-center supplementary material Symptom Transmission with COVID-19 [DOI] 10.1186/s13756-021-01031-5 PMC 바로가기 [Article Type] Research
Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March-August, 20202020년 3월-8월 미국 10개 사이트에서 시간 경과에 따른 중증 급성 호흡기 증후군 코로나바이러스 2 혈청 유병률의 변화Article Published on 2021-11-162022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] MERS, SARS, 진단, 치료기술, [키워드] absence acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adjusted age and sex anti-SARS-CoV-2 antibody antibody Antibody Response bootstrap change changes in clinical testing complement confidence Confidence intervals coronavirus coronavirus 2 COVID-19 cumulative cumulative incidence decrease decreases detectable estimate Estimated Evidence evidence of incidence infected with SARS-CoV-2 Infection interval Laboratory majority monitoring New York over performed population level Prevalence reached remained repeated reported respiratory SARS-CoV-2 SARS-COV-2 infection serologic testing serology Seroprevalence serum severe acute respiratory syndrome Coronavirus significant decrease significant increases in Site South statistically significant the United State The United States time United States Utah Washington [DOI] 10.1093/cid/ciab185 PMC 바로가기 [Article Type] Article
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity코로나바이러스 질병 2019(COVID-19) 심각도의 바이러스 역학 및 면역 상관관계Observational Study Published on 2021-11-022022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] MERS, SARS, 임상, 진단, [키워드] age Antibody Response association Characteristics chemokine Clinical severity collected Comorbidities coronavirus 2 correlated COVID-19 Culture Cytokines disease severity Dynamics evaluated HGF IgM IgM and IgG IgM/IgG IL-12p70 IL-18 IL-1ra IL-6 immune markers immune response immune signature immunology Immunotherapy Infection Inflammatory cytokine Invasive mechanical ventilation IP-10 IQR knowledge Level MCP-1 median MIP-1α occurred offer overactive Patient PCR PCR cycle PCR-confirmed plasma sample positive proinflammatory prospective observational cohort Randomized controlled trials required respiratory respiratory sample SARS-CoV-2 SARS-COV-2 infection Seroconversion seroconverted serologic testing serology serum sample severity significantly supplemental oxygen symptom onset target threshold viability viral culture viral dynamics Viral pneumonia virus [DOI] 10.1093/cid/ciaa1280 PMC 바로가기 [Article Type] Observational Study
Seroprevalence of SARS-CoV-2–Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020Research Published on 2021-11-012022-10-31 Journal: Emerging Infectious Diseases [Category] COVID-19, MERS, [키워드] 2019 novel coronavirus disease acute respiratory syndrome antibodies antibody close contact close contacts Contact coronavirus disease Coronaviruses COVID-19 COVID-19 patient Faroe Islands General population help high risk higher risk household Infection Participants Patient quarantine respiratory infections SARS-CoV-2 SARS-CoV-2 seroprevalence SARS-CoV-2–specific antibody secondary attack rate serologic testing seropositive Seroprevalence severe acute respiratory syndrome coronavirus 2 transmission of SARS-CoV-2 viruses zoonoses [DOI] 10.3201/eid2711.204948 PMC 바로가기 [Article Type] Research
Understanding the Patterns of Serological Testing for COVID-19 Pre- and Post-Vaccination Rollout in MichiganArticle Published on 2021-09-242022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] age Analysis association black Characteristics collected conditions Coronavirus disease 2019 COVID-19 COVID-19 infection COVID-19 vaccine determine disease Disease prevalence Factor health center identify Immunity individual individuals Infection Liver disease Medicine pattern Post-vaccine presenting provided relative remained Respiratory disease SARS-CoV-2 antibody SARS-CoV-2 antibody test serologic testing Seropositivity Sex significantly smoking statistically significant tested Testing understanding vaccinated individual vaccinated individuals vaccination Vaccine-induced immunity variables was performed [DOI] 10.3390/jcm10194341 PMC 바로가기 [Article Type] Article
SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British ColumbiaSARS-CoV-2 혈청학: 브리티시컬럼비아에서 고처리량 화학발광 면역분석(CLIA) 플랫폼 및 현장 연구 검증Article Published on 2021-09-012022-09-11 Journal: Journal of Clinical Virology [Category] SARS, 진단, 치료기술, [키워드] Abbott addition adjunct Antibody testing assays automated Care chemiluminescent immunoassay CLIA collected COVID-19 demonstrated diagnose diagnoses DiaSorin Disease prevalence Elecsy evaluated field Infection LIAISON molecular Negative predictive value Ortho Vitros outbreak Outbreak investigation outbreak investigations PCR PCR testing performed platform Positive predictive value positive predictive values post-symptom onset PPV predictive values Prevalence required Roche S1/S2 SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 antibody testing sensitivities sensitivity Sensitivity and specificity serologic serologic testing serology Siemen Siemens Specificities tested Total vaccine response validation validation study [DOI] 10.1016/j.jcv.2021.104914 PMC 바로가기 [Article Type] Article
Expanding access to SARS-CoV-2 IgG and IgM serologic testing using fingerstick whole blood, plasma, and rapid lateral flow assays핑거스틱 전혈, 혈장 및 신속한 측면 흐름 분석을 사용하여 SARS-CoV-2 IgG 및 IgM 혈청학적 검사에 대한 접근 확대Article Published on 2021-08-012022-09-12 Journal: Journal of Clinical Virology [Category] MERS, SARS, 진단, [키워드] Abbott antibodies Asymptomatic automated Blood can be used capillary blood collected Concordance controls convalescent plasma DBS sample DBS samples Diagnosis disease donors Dried blood spots Efficacy examined expand fingerstick IgM lateral flow linearity Microtainer Patient PCR-confirmed COVID-19 plasma plasma sample point-of-care positive R 2 Rapid rapid diagnostics reproducibility SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 testing serologic serologic testing serology testing stability Symptom Vaccine venous Whole blood whole blood sample [DOI] 10.1016/j.jcv.2021.104855 PMC 바로가기 [Article Type] Article
Methods matter – Tailoring SARS-CoV-2 antibody targets to vaccination status방법이 중요 - 백신 접종 상태에 맞게 SARS-CoV-2 항체 표적 조정Article Published on 2021-08-012022-09-11 Journal: Clinica chimica acta; international journal of cli [Category] MERS, SARS, 진단, 치료법, [키워드] Anti-spike antibody assay Antibody test Antibody testing antibody tests Antigen approach Confusion COVID-19 COVID19 delineation develop IgG IgG antibody individual Infection Interpretation Laboratory mRNA vaccination nucleocapsid protein patient population SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 antibody testing serologic testing specific antigen spike Spike protein target the spike protein the vaccine vaccination Vaccine development [DOI] 10.1016/j.cca.2021.04.009 PMC 바로가기 [Article Type] Article